The supply of cisplatin, carboplatin and methotrexate has nearly halved in the past year
Pfizer/BioNTech and Moderna’s updated vaccines will be available in the coming days
Treatment options for the underdiagnosed and rapidly progressive condition are currently limited
The vaccines have both been adapted to target the currently circulating XBB.1.5 Omicron variant
Around 180,000 patients with type 2 diabetes could benefit from the new treatment option
Bimzelx is now recommended to treat certain patients with psoriatic arthritis and axial spondyloarthritis, two forms of chronic inflammatory arthritis
One in 500 people in the UK are affected by hypertrophic cardiomyopathy
Approximately 7.2 million people in the UK are affected by the long-term kidney condition
The updated vaccine proved effective against the currently circulating XBB.1.5 subvariant
‘Post-Brexit landscape for EU-wide IP Rights: The Story So Far’Brexit means pharma must review its intellectual property rights across Europe
Moving timesContinuity and stability are vital when it comes to the EMA's relocation when it leaves London
SMC gives green light for Amgen’s KyprolisThe committee also gives verdict on three other products
Novartis sues US government over Medicare drug price negotiation programmeThe action comes after the first drugs subject to pricing negotiations were announced
Amgen free to proceed with $27.8bn Horizon acquisition following US FTC settlementThe FTC filed an antitrust lawsuit against Amgen earlier this year in a bid to block the transaction
NICE recommends Chiesi’s Elfabrio for adults with Fabry diseaseAffecting approximately 1,150 people in England, Fabry disease is a rare genetic disease that can lead to progressive damage to vital organs
Pfizer and BioNTech’s XBB.1.5-adapted COVID-19 vaccine approved by ECThe vaccine is approved for use in adults, children and infants over six months
MHRA grants two new marketing authorisations for UCB's inflammatory disease drug治疗银屑病arthrit Bimzelx现在批准is and axial spondyloarthritis
Pfizer and BioNTech’s XBB.1.5-adapted COVID-19 vaccine recommended by CHMPimmediatel剂量将准备船y upon authorisation by the European Commission
Merck receives EC approval for Keytruda combination in gastric cancerOver one million new cases of gastric cancer were diagnosed globally in 2020
EFPIA confirms first and second vice-presidentsNovo Nordisk CEO Lars Fruergaard Jørgensen appointed first vice-president and Servier president Olivier Laureau confirmed as second vice-president
EFPIA appoints Hubertus von Baumbach as presidentVon Baumbach will serve as president of the EFPIA for the next two years
ABPI appoints industry veteran Richard Torbett as new chief executiveTorbett initially joined the pharma association in March 2016
Professor Carole Longson moves from NICE to the ABPIShe joins the UK pharma body as its chief scientific officer
MedTech Europe appoints new board of directorsChair of the board Michelle Brennan is among those newly elected
No results were found
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors...
